COVID-19 Drug Repurposing: A Network-Based Framework for Exploring Biomedical Literature and Clinical Trials for Possible Treatments.
Ahmed Abdeen HamedTamer E FandyKarolina L TkaczukKarin M VerspoorByung Suk LeePublished in: Pharmaceutics (2022)
Our framework has identified treatments in the form of two, three, or four drug combinations (e.g., hydroxychloroquine, doxycycline, and azithromycin). The identifications of the various treatment candidates provided sufficient evidence that supports the trustworthiness of our hypothesis.